Endocarditis
From Anvita Health Wiki
Contents |
Etiology
- common microbiologic causes (see common organisms by study)
- native valve
- Streptococci
- Staphylococci ( S aureus most common cause)
- Gram-negative rods
- uncommon microbiologic causes
- HACEK bacterial group (Haemophilus, Actinobacillus, Cardiobacterium, Eikenella, Kingella)
- anaerobes
- Chlamydia
- Rickettsia
- Brucella
- Legionella
- Coxiella
- viruses
- culture negative infectious endocarditis (3-5%)
- prior antibiotics
- fastidious organisms
- viral or fungal etiology
- indolent tricuspid valve disease
- non infectious endocarditis
- risk factors for endocarditis
- prosthetic heart valve*
- congenital heart disease: Tetralogy of Fallot
- rheumatic heart disease
- mitral valve prolapse with regurgitation
- prior endocarditis*
- Marfan's syndrome
- valvular stenosis
- valvular insufficiency
- hypertrophic cardiomyopathy
- intravenous drug abuse ( IVDA)
- central venous catheters
- hemodialysis catheters & shunts
- wires from pacemakers & implantable defibrillators
- recent dental work or surgery
- * high-risk of endocarditis
Epidemiology
- mean age of patients is > 50 years
Pathology
- valve-ring abscess
- valvular perforation
- valvular rupture
- myocardial abscess
- valvular stenosis secondary to large vegetations
- systemic embolization
- mycotic aneurysms
- kidney (common)
- renal abscess
- renal embolization & infarction
- glomerulonephritis
- CNS involvement
- ischemic stroke secondary to cardiac emboli
- cerebral vasculitis
- meningitis
- cerebral abscess
- subarachnoid hemorrhage due to ruptured mycotic aneurysm
- affected valves:
- single valve involvement
- involvement of right & left heart valves (3-5%)
- involvement of both aortic & mitral valves (30-35%)
- heroin associated with right-sided endocarditis [6]
Clinical-manifestations
- protean manifestations due to:
- cardiac complications of valvular dysfunction
- bacteremia
- bland or septic emboli
- circulating immune complexes
- common manifestations
- fever/ chills (90-95%)
- bacteremia
- malaise
- heart murmur (> 80%)
- embolic phenomena - focal neurologic signs
- congestive heart failure
- cough, pleuritic chest pain & pneumonia more common in right-sided endocarditis ( IV drug abuse)
- uncommon manifestations
- splenomegaly
- retinal lesions ( Roth spots)
- meningitis
- cutaneous manifestations
Diagnostic-criteria
Laboratory
-
- normocytic anemia
- leukocytosis
- monocytosis (< 25%)
- urinalysis (abnormal < 65%)
- blood cultures (positive in > 93%)
- antibiotic sensitivities
- determination of the minimum inhibitory ( MIC) & minimum bactericidal concentration ( MBC)
- assess aminoglycoside synergy for penicillin-resistant streptococci & enterococci
- Schlicter test
- erythrocyte sedimentation rate (ESR) increased in > 90%
Diagnostic-procedures
- electrocardiogram ( ECG) - may show conduction abnormalities
- echocardiogram
-
- all septic or bacteremic patients
- TTE with lower sensitivity than TEE, but better specificity
- septic or bacteremic patients with negative TTE
- better sensitivity than transthoracic echo, but higher incidence of false positives
- patients with prosthetic valves
- perivalvular abscess
- role of echocardiography in assessing prognosis or need for surgery is controversial
- colonoscopy to assess colon cancer in patients with blood cultures positive for:
- Streptococcus bovis
- Clostridium septicum [4]
Radiology
- chest X-ray may show multiple bilateral small nodules
- multislice computed tomography ( CT) may be alternative to TEE [7]
Complications
- embolic strokes are common with left-sided endocarditis, but often clinically silent
- in- hospital or 14.7% & 1-year mortality of 23.2% when associated with cardiac device ( pacemaker, mechanical valve) [11]
Management
- general considerations
- 4-6 weeks duration of therapy*
- use of synergistic combinations of antibiotics
- selection of antibiotic(s) on the basis of an isolated organism (see laboratory)
- recognition of indications for surgical management
- empiric therapy (after obtaining blood cultures)
- community-acquired endocarditis
- vancomycin plus gentamicin, or
- ampicillin sulbactam ( Unasyn) plus gentamicin
- nosocomial endocarditis
- vancomycin, gentamicin + rifampin ( S epidermidis) + antipseudomonas penicillin or beta-lactam antibiotic (gram-negative baccilli)
- specific organisms
-
-
- penicillin G 10-20 million units IV QD for 4 weeks +/- 2 weeks of gentamicin 1 mg/kg IV every 8 hours
- vancomycin 15 mg/kg IV every 12 hours for 4 weeks
- penicillin G 20 million units IV QD plus Gentamicin 1 mg/kg every 8 hours for 6 weeks
- ampicillin 2 g IV every 6 hours plus Gentamicin 1 mg/kg every 8 hours for 6 weeks
- vancomycin 15 mg/kg IV every 12 hours plus Gentamicin 1 mg/kg every 8 hours for 6 weeks
- Enterococcus - treat as penicillin-resistant Streptococcus
- Staphylococcus
- nafcillin 1.5-2.0 g IV every 4 hours for 4-6 weeks plus gentamicin 1 mg/kg IV every 8 hours for 5-7 days
- vancomycin 15 mg/kg IV every 12 hours plus rifampin 300 mg PO every 12 hours for 4-6 weeks plus gentamicin 1 mg/kg IV every 8 hours for 5-7 days
- cephalothin 2 gm IV every 6 hours for 4-6 weeks plus gentamicin 1 mg/kg IV every 8 hours for 5-7 days
- Enteric gram-negative bacilli ( E coli, Klebsiella, Proteus, Pseudomonas, Serratia)
- cephalosporin or broad-spectrum penicillin plus an aminoglycoside determined by antibiotic sensitivity for 6 weeks
- left-sided endocarditis due to Pseudomonas or Serratia may require combined medical & surgical intervention
- prognosis poor
- antifungal agents with poor activity
-
- Staphylococcus aureus & epidermidis, diphtheroids
- amphotericin B + 5-FC + surgery consult
- indications for surgery [9]
-
- progressive congestive heart failure [10]
- recurrent embolization
- antibiotic- refractory disease
- persistent bacteremia (> 3 days) on appropriate antibiotics
- extravalvular intracardiac abscess (ring abscess)
- mycotic aneurysm
- any treatment failure with prosthetic valve endocarditis
- prosthetic valve endocarditis caused by fungi, Pseudomonas aeruginosa or Staphylococcus aureus
- severe cardiac valvular dysfunction identified by echocardiography
- * special case of right-sided endocarditis caused by methicillin-sensitive S. aureus may be treated by 2 weeks of IV nafcillin + an aminoglycoside [4]
- see prophylaxis for bacterial endocarditis
More General Terms
Additional Terms
- antibiotic prophylaxis for bacterial endocarditis
- Duke criteria for diagnosis of infectious endocarditis
- empiric antibiotic therapy
- etiology of bacterial endocarditis, common organism
- Janeway spot or lesion (smoke ring)
- Osler's node
- Slichter test
References
- Saunders Manual of Medical Practice, Rakel (ed), WB Saunders, Philadelphia, 1996, pg 265-67
- Dajani AS et al Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA 1990, 264:2919 PMID: [1]
- Harrison's Principles of Internal Medicine, 14th ed. Fauci et al (eds), McGraw-Hill Inc. NY, 1998, pg 785-91
- Medical Knowledge Self Assessment Program (MKSAP) 11, 14, American College of Physicians, Philadelphia 1998, 2006
- Snygg-Martin U et al, Cerebrovascular complications in patients with left-sided infective endocarditis are common: A prospective study using magnetic resonance imaging and neurochemical brain damage markers. Clin Infect Dis 2008, 47:23 PMID: [2]
- Baddour LM and Bayer AS. Cerebrovascular complications in patients with left-sided infective endocarditis: Out of site, out of mind. Clin Infect Dis 2008, 47:31 PMID: [3] - Jain V et al. Infective endocarditis in an urban medical center: Association of individual drugs with valvular involvement. J Infect 2008 Aug; 57:132. PMID: [4]
- Feuchtner GM et al. Multislice computed tomography in infective endocarditis: Comparison with transesophageal echocardiography and intraoperative findings. J Am Coll Cardiol 2009 Feb 3; 53:436. PMID: [5]
- Fowler VG et al, Staphylococcus aureas Endocarditis: A Consequence of Medical Progress JAMA 2005, 293(24):3012 PMID: [6]
- Lalani T et al. Analysis of the impact of early surgery on in-hospital mortality of native valve endocarditis: Use of propensity score and instrumental variable methods to adjust for treatment-selection bias. Circulation 2010 Mar 2; 121:1005. PMID: [7]
- Kiefer T et al. Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure. JAMA Nov 23/30; 306:2239. PMID: [8]
- Athan E et al. Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices. JAMA 2012 Apr 25; 307:1727. PMID: [9]
- National Guideline Clearinghouse Suspected infective endocarditis. (American College of Radiology) ngc-guideline: [10]
- Prevention of infective endocarditis: guidelines from the American Heart Association. ngc-guideline: [11]
- Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009) European Society of Cardiology ngc-guideline: [12]
